Janney Montgomery Scott’s Sage Therapeutics SAGE Stock Holding History

Janney Montgomery Scott’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,008	Closed	-$562K	–	2124
2019 Q3	$562K	Sell	4,008 -549	-12%	-$91.8K	﹤0.01%	1326
2019 Q2	$834K	Buy	4,557 +219	+5%	+$37.4K	0.01%	1142
2019 Q1	$690K	Buy	4,338 +27	+0.6%	+$3.91K	0.01%	1215
2018 Q4	$413K	Sell	4,311 -1,496	-26%	-$171K	﹤0.01%	1398
2018 Q3	$820K	Buy	5,807 +210	+4%	+$32.4K	0.01%	1157
2018 Q2	$876K	Buy	5,597 +1,080	+24%	+$170K	0.01%	1053
2018 Q1	$728K	Buy	4,517 +1,699	+60%	+$288K	0.01%	1115
2017 Q4	$464K	Buy	+2,818	New	+$273K	﹤0.01%	1344
2017 Q2	–	Sell	-3,599	Closed	-$256K	–	1796
2017 Q1	$256K	Buy	+3,599	New	+$211K	﹤0.01%	1494

Other funds holding SAGE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Janney Montgomery Scott's SAGE Position: Q4 2019 in Review

Janney Montgomery Scott sold out of Sage Therapeutics (SAGE) in Q4 2019, closing a stake of 4,008 shares — an estimated $562K sold.

Janney Montgomery Scott first reported a position in SAGE in Q1 2017 and held it in 9 quarters. The position peaked at $876K in Q2 2018. 267 funds tracked by Wall St. Rank hold SAGE as of Q4 2019.

Janney Montgomery Scott reported no remaining Sage Therapeutics position as of Q4 2019 after selling out during the quarter.
Janney Montgomery Scott sold 4,008 Sage Therapeutics shares in Q4 2019, an estimated $562K.
Janney Montgomery Scott first reported a position in Sage Therapeutics in Q1 2017 and held it in 9 quarters.
Janney Montgomery Scott's Sage Therapeutics position peaked at $876K in Q2 2018.
267 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2019.

Based on Janney Montgomery Scott's 13F filing for Q4 2019, filed 21 Jan 2020.